Featured Research

from universities, journals, and other organizations

Molecules Inhibit HIV Protease, Could Lead To New Line Of Attack Against AIDS

Date:
January 25, 2001
Source:
American Chemical Society
Summary:
Researchers have identified a molecule with the ability to inhibit a key enzyme of HIV, a finding that could limit the spread of the virus that causes AIDS. The laboratory test results are reported in the February 7 issue of the Journal of the American Chemical Society, a peer-reviewed journal of the American Chemical Society.

Researchers have identified a molecule with the ability to inhibit a key enzyme of HIV, a finding that could limit the spread of the virus that causes AIDS. The laboratory test results are reported in the February 7 issue of the Journal of the American Chemical Society, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society.

Known as polyoxometalate, or POM, the molecule stopped HIV protease at a molecular location away from its "active site," according to Craig Hill, an author of the paper and chemistry professor at Emory University in Atlanta. The preliminary research is the first report of such inhibition, which Hill believes could - in combination with conventional HIV drugs - reduce the chances of spreading the virus, particularly drug-resistant strains.

HIV protease forms proteins at its active site that can lead to the virus. The virus can then replicate itself throughout the body. The POM molecule provides a "second line of attack" against HIV away from the active site, Hill noted. Preventing protease activity is not a cure for HIV, but could help manage the virus's spread and delay the onset of full-blown AIDS.

Since HIV can become resistant to existing drugs, the POM molecule would likely function as a complementary treatment along with known protease inhibitors and reverse transcriptase inhibitors like AZT, Hill said.

"Basically it's really interesting scientifically, but we're not quite sure what it means to patients with HIV just yet," Hill said. "This work documents, in a very concrete way, a new mode of inhibition of the HIV protease by a small molecule."

The POM family includes more than 10,000 molecules. Some have been used commercially as catalysts and others possess known antiviral activities. The researchers were surprised to discover that the POM molecule inhibited protease, Hill said. The finding defies conventional wisdom that effective drugs must bind at the enzyme's active site, he added.

More laboratory work must be done before clinical testing of the POM molecules can begin, Hill said. Clinical approval and use of the POM molecules in drug form, therefore, is too far in the future to predict, he continued.

The research cited above was funded by research grants from the Molecular Design Institute in the Office of Naval Research, part of the U.S. Department of Defense, and the U.S. National Institutes of Health.

Craig Hill, Ph.D., is a professor in the department of chemistry at Emory University in Atlanta.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Molecules Inhibit HIV Protease, Could Lead To New Line Of Attack Against AIDS." ScienceDaily. ScienceDaily, 25 January 2001. <www.sciencedaily.com/releases/2001/01/010125082418.htm>.
American Chemical Society. (2001, January 25). Molecules Inhibit HIV Protease, Could Lead To New Line Of Attack Against AIDS. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2001/01/010125082418.htm
American Chemical Society. "Molecules Inhibit HIV Protease, Could Lead To New Line Of Attack Against AIDS." ScienceDaily. www.sciencedaily.com/releases/2001/01/010125082418.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins